MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas-Reference-Cited by-同舟云学术

MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas

Published:2017-08-28 Issue:1 Volume:57 Page:32-43
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Liu Mei¹,An Jusheng²,Huang Manni²,Wang Liming³,Tu Binbin²,Song Yan⁴,Ma Kai¹,Wang Yu¹,Wang Shuren¹,Zhu Hongxia¹,Xu Ningzhi¹⁵^ORCID,Wu Lingying²

Affiliation:

1. Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing P. R. China

2. Department of Gynecological Oncology; National Cancer Center/Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing P. R. China

3. Department of Abdominal Surgery; National Cancer Center/Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing P. R. China

4. Department of Pathology; National Cancer Center/Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing P. R. China

5. State Key Laboratory of Biotherapy and Cancer Center; West China Hospital; Sichuan University, Collaborative Innovation Center for Biotherapy; Chengdu P. R. China

Funder

National Natural Science Foundation of China

Chinese Academy of Meteorological Sciences

National Basic Research Program of China

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference37 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix-worldwide;Mathew;Asian Pac J Cancer Prev,2009

3. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01;Eifel;J Clin Oncol,2004